Eli Lilly's recently approved therapy Olumiant improved systemic lupus erythematosus (SLE) compared to placebo in a global Phase 2 study presented at the this year's Annual European Congress of Rheumatology, or EULAR, in the Netherlands.
Paediatric Lupus Needs Early Treatment to Reduce Disease Activity, Prevent Organ Damage, Study Says
Obesity in Women Worsens Lupus, Increases Depression, Pain and Fatigue, Study Finds
Feinstein Institute researchers find blood markers that identify lupus risk.
Increased Arterial Stiffness Observed in Patients with Systemic Lupus Erythematosus
New Drug Trial Aims to Help Collect Data to Treat Lupus Patients
Severance Hospital Korea finds new treatment method for lupus nephritis
Benlysta Use Found to Be Safe and Effective
Studies by researchers at UT Southwestern Medical Center could lead to new treatments for lupus
Influence of ethnicity on childhood-onset systemic lupus erythematosus: Results from a multi-ethnic multicenter Canadian cohort.
Canadian Institute of Health Research. Research: Lupus drugs carry no significant cancer risk for patients
New hope for lupus patients
A clinical trial with 149 patients suffering from systemic lupus, has shown the effectiveness of a synthetic peptide developed by a team of researchers led by CNRS biologist Slyviane Muller at the Institut de Biologie Moleculaire (IBMC) in Strasbourg, France.
University of Louisville School of Medicine Researchers identify gene variants that may cause kidney problems in lupus patients
Researchers unravel how DNA damage may trigger lupus erythematosus
RCSI Researcher finds Irish Lupus patients likely to benefit from new treatment
Takeda And Resolve Therapeutics To Develop Lupus Treatments
Osaka-based Takeda Pharmaceutical Company Limited and U.S. biotech Resolve Therapeutics, LLC have entered into a partnership to develop compounds for the treatment of lupus and other autoimmune diseases.
Does Lupus Increase Risk of Psychiatric Issues?
Despite more than half of the cohort taking vitamin D supplements, 58% of Thai patients with SLE had vitamin D deficiency or insufficiency...
Researchers in Thailand conducted a cross-sectional study of 101 patients with systemic lupus erythematosus (SLE; mean age, 40.13 years; 96% women). Blood samples were collected and stored. Radioimmunoassay was used to measure levels of serum 25(OH) vitamin D (25[OH]D). Vitamin D deficiency and insufficiency were considered at 30 ng/mL and 20 ng/mL, respectively. After demographic, clinical and laboratory data were collected, univariate and multivariate linear regression analyses were used to examine their associations with 25(OH)D level.
Despite its prevalence, leukopenia typically was not persistent or a risk factor for severe infection among patients with SLE, according to recent study results by researchers in Thailand.
Despite its prevalence, leukopenia typically was not persistent or a risk factor for severe infection among patients with SLE, according to recent study results by researchers in Thailand.
